Hip Reconstruction Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

Hip Reconstruction Pipeline Market Overview

Hip Reconstruction or Hip Replacement is a procedure that involves replacement of the damaged or diseased parts of the hip joint. The hip reconstruction category includes devices (implants) used in the hip replacement procedures. A hip replacement is a common type of surgery where a damaged hip joint is replaced with an artificial one or an implant. Modern artificial hip joints are generally designed to last for 15 years or more.

The hip reconstruction pipeline report covers key segments and detailed product development stage analysis. The report also includes information about the territories wherein the clinical trials are in progress, the regulatory paths followed, and the companies associated with the trials.

Key Segment ·       Primary Hip Replacement

·       Revision Hip Replacement

·       Hip Resurfacing

·       Primary Cemented Hip Replacement

·       Partial Hip Replacement

Key Territory ·       The US

·       China

·       Europe

·       Japan

·       India

Key Regulatory Paths ·       510(k)

·       CE

·       NMPA

·       PMA

·       Shonin

Leading Companies ·       4WEB Medical Inc

·       Arigin Medical Co Ltd

·       Athroa Innovations

·       Bactiguard Holding AB

·       Beijing Ansong Technology Co Ltd

Enquire & Decide Discover the perfect solution for your business needs. Enquire now and let us help you make an informed decision before making a purchase.

Hip Reconstruction Pipeline Market Segmentation by Segments

The key segments in the hip reconstruction pipeline market are primary hip replacement, revision hip replacement, hip resurfacing, primary cemented hip replacement, and partial hip replacement among others. As of June 2024, the primary hip replacement segment accounts for the largest number of products in pipeline.

Hip Reconstruction Pipeline Market Analysis by Segments, 2024 (%)

Hip Reconstruction Pipeline Market Analysis by Segments, 2024 (%)

Buy the Full Report for More Segment Insights into the Hip Reconstruction Pipeline Market

Download a Free Report Sample

Hip Reconstruction Pipeline Market Segmentation by Territories

A few of the key territories with the hip reconstruction pipeline market are the US, China, Europe, Japan, and India among others. As of June 2024, the US accounts for the highest number of hip reconstruction pipeline products.

Hip Reconstruction Pipeline Market Analysis by Territories, 2024 (%)

Hip Reconstruction Pipeline Market Analysis by Territories, 2024 (%)

Buy the Full Report for More Territory Insights into the Hip Reconstruction Pipeline Market
Download a Free Report Sample

Hip Reconstruction Pipeline Market Segmentation by Regulatory Paths

A few of the key regulatory paths in the hip reconstruction pipeline products market are 510(k), CE, NMPA, PMA, and Shonin among others. As of June 2024, 510(k) accounts for the most followed pathway for pipeline products in the hip reconstruction market.

Hip Reconstruction Pipeline Market Analysis by Regulatory Paths, 2024 (%)

Hip Reconstruction Pipeline Market Analysis by Regulatory Paths, 2024 (%)

Buy the Full Report for More Regulatory Path Insights into the Hip Reconstruction Pipeline Market

Download a Free Report Sample

Hip Reconstruction Pipeline Market – Competitive Landscape

A few of the key companies associated with the hip reconstruction pipeline market are 4WEB Medical Inc., Arigin Medical Co. Ltd., Athroa Innovations, Bactiguard Holding AB, and Beijing Ansong Technology Co Ltd among others.

4WEB Medical Inc: 4WEB Medical Inc (4WEB) is an orthopedic implant device company that designs 3D printed titanium implants. The company also designs and develops implants for trauma, tumor, and patient-specific applications. Its product portfolio includes anterior, posterior, cervical, and lateral spine truss systems, as well as the osteotomy truss system and implant custom services for extremity, tumor, and trauma procedures. It utilizes 3D printing technology to develop 4WEB Medical’s proprietary truss implant platform. 4WEB is headquartered in Frisco, Texas, the US.

Athroa Innovations: Athroa Innovations is engaged in providing operational and financial support to start-up companies to enhance the growth. It invests in clean technology, healthcare technology, and other sectors. The company is headquartered in Athens, Attica, Greece.

Hip Reconstruction Pipeline Market Analysis by Companies, 2024

Hip Reconstruction Pipeline Market Analysis by Companies, 2024

Buy the Full Report for More Company Insights into the Hip Reconstruction Pipeline Market

Download a Free Report Sample

Segments Covered in the Report

Hip Reconstruction Pipeline Market Segments Outlook (2024)

  • Primary Hip Replacement
  • Revision Hip Replacement
  • Hip Resurfacing
  • Primary Cemented Hip Replacement
  • Partial Hip Replacement

 

Hip Reconstruction Pipeline Market Territories Outlook (2024)

  • The US
  • China
  • Europe
  • Japan
  • India

Hip Reconstruction Pipeline Market Regulatory Paths Outlook (2024)

  • 510(k)
  • CE
  • NMPA
  • PMA
  • Shonin

Scope

This report provides:

  • Extensive coverage of the hip reconstruction under development.
  • An exhaustive list of major pipeline products and their details, including product description, licensing and collaboration details, and other developmental activities.
  • Reviews of major players involved in the development of hip reconstruction and lists all their pipeline projects.
  • Coverage of pipeline products based on various stages of development ranging from early development to approved/issued stage.
  • Key clinical trial data of ongoing clinical trials specific to pipeline products.
  • Recent developments in the segment/industry.

Reasons to Buy

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies.
  • Identify emerging players with potentially strong product portfolios and create effective counter strategies to gain a competitive advantage.
  • Identify and understand important and diverse types of hip reconstruction under development.
  • Develop market-entry and market-expansion strategies.
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline.
  • Carry out an in-depth analysis of the product’s current stage of development, territory, and estimated launch date.

4WEB Medical Inc
Arigin Medical Co Ltd
Athroa Innovations
Bactiguard Holding AB
Beijing Ansong Technology Co Ltd
BioPoly LLC
Biotechni SAS
Bonovo Orthopedics Inc
Corin Group Ltd
CytexOrtho
DePuy Synthes Inc
Dynamic Implant Inc
Embody Orthopaedic Ltd
Exactech Inc
Flexable Orthopedics
Fortis Orthopedics
Fraunhofer Institute for Applied Polymer Research
Gyder Surgical Pty Ltd
Hip Innovation Technology LLC
Implants International Ltd
Inertial Orthopaedic Navigation Solutions (IONS) Pty Ltd
Inor Medical Products Ltd
JointMedica Ltd
JRI Orthopaedics Ltd
Lifespans Ltd
Limacorporate SpA
MicroPort Orthopedics Inc
MicroPort Scientific Corp
MX Orthopedics Corp
Nano Interface Technology LLC (Inactive)
Ortho Development Corp
OrthoGrid Systems Inc
Orthopaedic International Inc
PreSRV Ltd.
Pro-Dex Inc
Renova Orthopedics LLC (Inactive)
Rochester Institute of Technology
SINTEF
SINTX Technologies Inc
Smith & Nephew Plc
Stanford University
University of Auckland
University of Cincinnati
University of Maine
University of Oxford
University of South Florida
University of Southampton
University of Warwick
Zimmer Biomet Holdings Inc

Table of Contents

|1 Table of Contents 3

|1.1 List of Tables 7

|1.2 List of Figures 11

2 Introduction 12

2.1 Hip Reconstruction Overview 12

3 Products under Development 14

3.1 Hip Reconstruction – Pipeline Products by Stage of Development 14

3.2 Hip Reconstruction – Pipeline Products by Segment 15

3.3 Hip Reconstruction – Pipeline Products by Territory 16

3.4 Hip Reconstruction – Pipeline Products by Regulatory Path 17

3.5 Hip Reconstruction – Pipeline Products by Estimated Approval Date 18

3.6 Hip Reconstruction – Ongoing Clinical Trials 19

4 Hip Reconstruction – Pipeline Products under Development by Companies 20

4.1 Hip Reconstruction Companies – Pipeline Products by Stage of Development 20

4.2 Hip Reconstruction – Pipeline Products by Stage of Development 22

5 Hip Reconstruction Companies and Product Overview 24

5.1 4WEB Medical Inc Company Overview 24

5.1.1 4WEB Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 24

5.2 Arigin Medical Co Ltd Company Overview 25

5.2.1 Arigin Medical Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 25

5.3 Athroa Innovations Company Overview 26

5.3.1 Athroa Innovations Pipeline Products & Ongoing Clinical Trials Overview 26

5.4 Bactiguard Holding AB Company Overview 27

5.4.1 Bactiguard Holding AB Pipeline Products & Ongoing Clinical Trials Overview 27

5.5 Beijing Ansong Technology Co Ltd Company Overview 28

5.5.1 Beijing Ansong Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 28

5.6 BioPoly LLC Company Overview 29

5.6.1 BioPoly LLC Pipeline Products & Ongoing Clinical Trials Overview 29

5.7 Biotechni SAS Company Overview 30

5.7.1 Biotechni SAS Pipeline Products & Ongoing Clinical Trials Overview 30

5.8 Bonovo Orthopedics Inc Company Overview 32

5.8.1 Bonovo Orthopedics Inc Pipeline Products & Ongoing Clinical Trials Overview 32

5.9 Corin Group Ltd Company Overview 34

5.9.1 Corin Group Ltd Pipeline Products & Ongoing Clinical Trials Overview 34

5.10 CytexOrtho Company Overview 35

5.10.1 CytexOrtho Pipeline Products & Ongoing Clinical Trials Overview 35

5.11 DePuy Synthes Inc Company Overview 37

5.11.1 DePuy Synthes Inc Pipeline Products & Ongoing Clinical Trials Overview 37

5.12 Dynamic Implant Inc Company Overview 39

5.12.1 Dynamic Implant Inc Pipeline Products & Ongoing Clinical Trials Overview 39

5.13 Embody Orthopaedic Ltd Company Overview 40

5.13.1 Embody Orthopaedic Ltd Pipeline Products & Ongoing Clinical Trials Overview 40

5.14 Exactech Inc Company Overview 43

5.14.1 Exactech Inc Pipeline Products & Ongoing Clinical Trials Overview 43

5.15 Flexable Orthopedics Company Overview 45

5.15.1 Flexable Orthopedics Pipeline Products & Ongoing Clinical Trials Overview 45

5.16 Fortis Orthopedics Company Overview 46

5.16.1 Fortis Orthopedics Pipeline Products & Ongoing Clinical Trials Overview 46

5.17 Fraunhofer Institute for Applied Polymer Research Company Overview 47

5.17.1 Fraunhofer Institute for Applied Polymer Research Pipeline Products & Ongoing Clinical Trials Overview 47

5.18 Gyder Surgical Pty Ltd Company Overview 48

5.18.1 Gyder Surgical Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview 48

5.19 Hip Innovation Technology LLC Company Overview 49

5.19.1 Hip Innovation Technology LLC Pipeline Products & Ongoing Clinical Trials Overview 49

5.20 Implants International Ltd Company Overview 52

5.20.1 Implants International Ltd Pipeline Products & Ongoing Clinical Trials Overview 52

5.21 Inertial Orthopaedic Navigation Solutions (IONS) Pty Ltd Company Overview 53

5.21.1 Inertial Orthopaedic Navigation Solutions (IONS) Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview 53

5.22 Inor Medical Products Ltd Company Overview 54

5.22.1 Inor Medical Products Ltd Pipeline Products & Ongoing Clinical Trials Overview 54

5.23 JointMedica Ltd Company Overview 56

5.23.1 JointMedica Ltd Pipeline Products & Ongoing Clinical Trials Overview 56

5.24 JRI Orthopaedics Ltd Company Overview 57

5.24.1 JRI Orthopaedics Ltd Pipeline Products & Ongoing Clinical Trials Overview 57

5.25 Lifespans Ltd Company Overview 66

5.25.1 Lifespans Ltd Pipeline Products & Ongoing Clinical Trials Overview 66

5.26 Limacorporate SpA Company Overview 67

5.26.1 Limacorporate SpA Pipeline Products & Ongoing Clinical Trials Overview 67

5.27 MicroPort Orthopedics Inc Company Overview 68

5.27.1 MicroPort Orthopedics Inc Pipeline Products & Ongoing Clinical Trials Overview 68

5.28 MicroPort Scientific Corp Company Overview 73

5.28.1 MicroPort Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 73

5.29 MX Orthopedics Corp Company Overview 76

5.29.1 MX Orthopedics Corp Pipeline Products & Ongoing Clinical Trials Overview 76

5.30 Nano Interface Technology LLC (Inactive) Company Overview 77

5.30.1 Nano Interface Technology LLC (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 77

5.31 Ortho Development Corp Company Overview 78

5.31.1 Ortho Development Corp Pipeline Products & Ongoing Clinical Trials Overview 78

5.32 OrthoGrid Systems Inc Company Overview 79

5.32.1 OrthoGrid Systems Inc Pipeline Products & Ongoing Clinical Trials Overview 79

5.33 Orthopaedic International Inc Company Overview 80

5.33.1 Orthopaedic International Inc Pipeline Products & Ongoing Clinical Trials Overview 80

5.34 PreSRV Ltd. Company Overview 81

5.34.1 PreSRV Ltd. Pipeline Products & Ongoing Clinical Trials Overview 81

5.35 Pro-Dex Inc Company Overview 82

5.35.1 Pro-Dex Inc Pipeline Products & Ongoing Clinical Trials Overview 82

5.36 Renova Orthopedics LLC (Inactive) Company Overview 83

5.36.1 Renova Orthopedics LLC (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 83

5.37 Rochester Institute of Technology Company Overview 84

5.37.1 Rochester Institute of Technology Pipeline Products & Ongoing Clinical Trials Overview 84

5.38 SINTEF Company Overview 85

5.38.1 SINTEF Pipeline Products & Ongoing Clinical Trials Overview 85

5.39 SINTX Technologies Inc Company Overview 86

5.39.1 SINTX Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 86

5.40 Smith & Nephew Plc Company Overview 88

5.40.1 Smith & Nephew Plc Pipeline Products & Ongoing Clinical Trials Overview 88

5.41 Stanford University Company Overview 90

5.41.1 Stanford University Pipeline Products & Ongoing Clinical Trials Overview 90

5.42 University of Auckland Company Overview 92

5.42.1 University of Auckland Pipeline Products & Ongoing Clinical Trials Overview 92

5.43 University of Cincinnati Company Overview 93

5.43.1 University of Cincinnati Pipeline Products & Ongoing Clinical Trials Overview 93

5.44 University of Maine Company Overview 94

5.44.1 University of Maine Pipeline Products & Ongoing Clinical Trials Overview 94

5.45 University of Oxford Company Overview 95

5.45.1 University of Oxford Pipeline Products & Ongoing Clinical Trials Overview 95

5.46 University of South Florida Company Overview 96

5.46.1 University of South Florida Pipeline Products & Ongoing Clinical Trials Overview 96

5.47 University of Southampton Company Overview 98

5.47.1 University of Southampton Pipeline Products & Ongoing Clinical Trials Overview 98

5.48 University of Warwick Company Overview 99

5.48.1 University of Warwick Pipeline Products & Ongoing Clinical Trials Overview 99

5.49 Zimmer Biomet Holdings Inc Company Overview 101

5.49.1 Zimmer Biomet Holdings Inc Pipeline Products & Ongoing Clinical Trials Overview 101

6 Hip Reconstruction- Recent Developments 102

6.1 Jun 04, 2024: Medtronic Announces Dr. Goran Petrovski to Join Diabetes Medical Affairs Team 102

6.2 Jun 04, 2024: Medtronic Announces Retirement of Rob Ten Hoedt as Executive Vice President and President, Global Regions, Effective as of June 28, 2024 102

6.3 May 23, 2024: Orthofix Names Max Reinhardt President of Global Spine Business 102

6.4 May 08, 2024: Paragon 28 Reports First Quarter 2024 Financial Results and Reaffirms 2024 Net Revenue Guidance 102

6.5 May 06, 2024: Howmedica Osteonics Receives An Additional 510(k) Clearance For V40 Biolox Delta Ceramic Femoral Head 103

6.6 May 02, 2024: Paragon 28 to Present at the Bank of America Securities 2024 Healthcare Conference 103

6.7 May 02, 2024: Zimmer Biomet Announces First Quarter 2024 Financial Results 104

6.8 Apr 28, 2024: MicroPort Orthopedics Receives Additional 510(K) Clearance For MPO Hip Instrument 105

6.9 Apr 25, 2024: Materialise Reports First Quarter 2024 Results 105

6.10 Apr 24, 2024: Stryker Receives Additional 510(k) Clearance for Hip System 107

6.11 Apr 24, 2024: Medtronic Names Yarmela Pavlovic as Chief Regulatory Officer 108

6.12 Apr 23, 2024: MicroPort Orthopedics Receives 510(K) Clearance For Ceramic Femoral Head 108

6.13 Apr 23, 2024: Orthofix Schedules First Quarter 2024 Earnings Release and Conference Call for May 7, 2024 108

6.14 Apr 16, 2024: DePuy Ireland Receives Additional FDA 510(k) Clearance for Pinnacle Constrained Acetabular Liner 108

6.15 Apr 16, 2024: Orthofix Names Andres Cedron as New Chief Legal Officer 108

6.16 Apr 04, 2024: Paragon 28 Announces CFO Transition, Provides Preliminary Unaudited Net Revenue for First Quarter 2024, and Reaffirms Net Revenue Guidance for Fiscal Year 2024 109

6.17 Mar 25, 2024: Howmedica Osteonics Receives FDA 510(k) Clearance for Modular Dual Mobility (MDM) X3 Insert For MDM Liner 110

6.18 Mar 18, 2024: Lucas Vitale Joins Orthofix as Chief People and Business Operations Officer 110

6.19 Mar 14, 2024: Ortho Development Receives FDA Clearance on Trivicta Hip System 111

6.20 Mar 13, 2024: Medacta Group Reports Robust Revenue Growth of

19.5% at Constant Currency and Adjusted EBITDA Margin

26.3%, or

27.9% at Constant Currency in FY 2023 111

6.21 Mar 12, 2024: Medtronic To Present At Barclays Global Healthcare Conference 114

6.22 Feb 24, 2024: DePuy Ireland Receives 510(K) Clearance For EMPHASYS Dual Mobility System 114

6.23 Feb 22, 2024: Heraeus Medical Receives Additional 510(K) Clearance for COPAL Exchange G Hip Spacer 114

6.24 Feb 21, 2024: Orthofix Schedules Fourth Quarter and Full Year 2023 Earnings Release and Conference Call for March 5, 2024 115

6.25 Feb 17, 2024: Orchard Medical Development Receives 510(K) Clearance For Z1 Hip System 115

6.26 Feb 15, 2024: Reverse Hip Replacement System Unveiled at Global Orthopedic Surgery Meeting 115

6.27 Feb 14, 2024: Groundbreaking Innovation in Musculoskeletal Healthcare Takes Center Stage at AAOS 2024 Annual Meeting: CytexOrtho Named OrthoPitch Technology Competition Winner 116

6.28 Feb 13, 2024: HipInsight System Hits 3,000 Total Hip Replacement Case Milestone 117

6.29 Feb 12, 2024: Enovis to Highlight Latest Technologies Across the Orthopedic Care Continuum at 2024 AAOS Annual Meeting 118

6.30 Feb 12, 2024: Smith+Nephew to Attend AAOS 2024 Annual Meeting 119

6.31 Feb 12, 2024: Orthopaedic Experts Identify Best Practices for Wound Closure and Dressing Management in Total Knee and Total Hip Arthroplasty 119

6.32 Jan 31, 2024: Stryker Corp Reports Strong Q4 and Full Year 2023 Results; Forecasts Continued Growth 120

6.33 Jan 29, 2024: DePuy Orthopaedics Receives Additional 510(K) Clearance For SUMMIT DuoFix Hip Prosthesis – MR Conditional 120

6.34 Jan 29, 2024: DePuy Orthopaedics Receives Additional 510(K) Clearance For SUMMIT Cemented Hip Prosthesis – MR Conditional 120

6.35 Jan 29, 2024: DePuy Orthopaedics Receives Additional 510(K) Clearance For SUMMIT FX Cemented Hip Prosthesis – MR Conditional 120

6.36 Jan 29, 2024: DePuy Ireland Receives Additional 510(K) Clearance For SUMMIT Basic Press-Fit Hip Prosthesis – MR Conditional 121

6.37 Jan 15, 2024: IMPLANET Reports 2023 Annual Revenue of €7.4 Million 121

6.38 Jan 11, 2024: Mount Carmel Health System and Anthem Announce Multi-Year Contract with Enhanced Value-Based Health Care and Improved Data Connectivity 122

6.39 Jan 09, 2024: Orthofix Medical Announces Preliminary 2023 Fourth Quarter and Full-Year Net Sales Results 123

6.40 Jan 08, 2024: Medacta’s QUADRA-H hip stem achieves 13A exemplary quality rating from the British Orthopaedic Data Evaluation Panel (ODEP) 123

6.41 Jan 04, 2024: Serf Receives 510(K) Clearance For Novae Dual Mobility System 124

6.42 Jan 04, 2024: DePuy Ireland Receives 510(k) Clearance for CORAIL Cemented Femoral Stem 125

6.43 Jan 04, 2024: Stryker Obtains Additional 510(k) Clearance for Hip System 125

6.44 Jan 02, 2024: GYDER Surgical announces successful first surgical cases in India 125

6.45 Dec 12, 2023: Orthofix Announces Agreement with Engine Capital and Appointment of Three New Independent Directors to Further Advance Position as Leading Global Spine and Orthopedics Company 126

6.46 Nov 28, 2023: AK Medical : Voluntary Announcement Certification by NMPA 126

6.47 Nov 08, 2023: Orthofix Reports Third Quarter 2023 Results 127

6.48 Nov 02, 2023: Implantcast Receives 510(K) Clearance For Actinia Hip Stem 128

6.49 Oct 26, 2023: 3D Printing Pioneer Materialise Appoints Brigitte de Vet-Veithen as New CEO 129

6.50 Oct 25, 2023: HSS Appoints New Leadership in Neurology and Anesthesia 130

6.51 Oct 11, 2023: DePuy Ireland Receives Additional 510(K) Clearance For TriFlange II Acetabular Cup System 130

6.52 Oct 09, 2023: Medacta International Receives Additional 510(k) Clearance for Mpact Extension 130

6.53 Oct 09, 2023: Stryker to Host Investor Day 131

6.54 Oct 05, 2023: Enovis to Showcase New Surgical Innovations at AAHKS Annual Meeting 131

6.55 Oct 04, 2023: Medtronic Names Paolo Di Vincenzo President of the Neuromodulation Business 131

6.56 Oct 02, 2023: Stryker to Announce Financial Results for Its Third Quarter of Fiscal Year 2023 132

6.57 Sep 20, 2023: DePuy International Receives Additional 510(K) Clearance For Depuy 3D Additive Triflange Acetabular Cup 132

6.58 Sep 14, 2023: Smith & Nephew Brings BT Chief Financial Officer Simon Lowth to Board 132

6.59 Sep 14, 2023: New Non Executive Directors Join the Board at Med Tech Business 132

6.60 Sep 14, 2023: Smith & Nephew Announces Board Changes 132

6.61 Sep 12, 2023: Orthofix Announces Leadership Changes 133

6.62 Sep 05, 2023: Zimmer Biomet Announces Key Updates to Company’s Executive Leadership Team 134

6.63 Aug 29, 2023: Luna Pathways Improves Postoperative Care: Patient Journey and Clinical Outcomes Outperform the Industry 135

6.64 Aug 26, 2023: Medtronic Q2 2024 Earnings Estimates Increased by William Blair 136

6.65 Aug 22, 2023: Zimmer Biomet Announces Leadership Transition 136

6.66 Aug 17, 2023: Smith+Nephew launches OR3O Dual Mobility System in India for use in primary and revision hip arthroplasty 137

6.67 Aug 16, 2023: Novel Combination of Oral Ketamine and Aspirin Is Safe Form of Pain Medication after Total Knee Replacement Surgery 137

6.68 Aug 09, 2023: Beijing Chunlizhengda Medical Instruments Co. Announces Annual Report for the Year Ended 31 December 2022 138

6.69 Aug 08, 2023: Medtronic to Announce Financial Results for its First Quarter of Fiscal Year 2024 139

6.70 Aug 07, 2023: Healthpoint celebrates milestone of 100 robotically assisted surgeries 139

6.71 Jul 28, 2023: Smith & Nephew Receives 510(K) Clearance for TANDEM Hip System 140

6.72 Jul 28, 2023: Medacta Group Announces 2023 Half-Year Unaudited Top-Line Figures 140

6.73 Jul 25, 2023: Limacorporate Receives Additional 510(K) Clearance for Minima S System 141

6.74 Jul 10, 2023: implantcast Receives 510(k) Clearance for BethaLoc Stem Cementless HA 142

6.75 Jul 05, 2023: Xerxes Arthopedix Receives 510(k) Clearance for Xerxes Hip Stem 142

6.76 Jun 28, 2023: Hip Innovation Technology Announces Positive Clinical Study Data of Its Novel Reverse Hip Replacement System for the Treatment of Total Hip Arthroplasty 142

6.77 Jun 22, 2023: Global Medical Technology Leader Zimmer Biomet Increases Presence in Malaysia With a New Office and GBS Center 143

6.78 Jun 16, 2023: Smith & Nephew Receives Additional 510(k) Clearance for ACCORD Cable System 144

7 Appendix 145

7.1 Methodology 145

7.2 About GlobalData 148

7.3 Contact Us 148

7.4 Disclaimer 148

Table

Hip Reconstruction – Pipeline Products by Stage of Development 14

Hip Reconstruction – Pipeline Products by Segment 15

Hip Reconstruction – Pipeline Products by Territory 16

Hip Reconstruction – Pipeline Products by Regulatory Path 17

Hip Reconstruction – Pipeline Products by Estimated Approval Date 18

Hip Reconstruction – Ongoing Clinical Trials 19

Hip Reconstruction Companies – Pipeline Products by Stage of Development 20

Hip Reconstruction – Pipeline Products by Stage of Development 22

4WEB Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 24

Truss Implant – Hip Procedures – Product Status 24

Truss Implant – Hip Procedures – Product Description 24

Arigin Medical Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 25

Acetabular Cup – Product Status 25

Acetabular Cup – Product Description 25

Athroa Innovations Pipeline Products & Ongoing Clinical Trials Overview 26

Bone Fixation Device – Product Status 26

Bone Fixation Device – Product Description 26

Bactiguard Holding AB Pipeline Products & Ongoing Clinical Trials Overview 27

Bactiguard Hip Joint Reconstruction Implant – Product Status 27

Bactiguard Hip Joint Reconstruction Implant – Product Description 27

Beijing Ansong Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 28

Ceramic Hip Implant – Product Status 28

Ceramic Hip Implant – Product Description 28

BioPoly LLC Pipeline Products & Ongoing Clinical Trials Overview 29

Biopoly RS Partial Resurfacing System – Hip – Product Status 29

Biopoly RS Partial Resurfacing System – Hip – Product Description 29

Biotechni SAS Pipeline Products & Ongoing Clinical Trials Overview 30

MULTI-T64 – Product Status 30

MULTI-T64 – Product Description 30

MULTI-T66 – Product Status 31

MULTI-T66 – Product Description 31

Bonovo Orthopedics Inc Pipeline Products & Ongoing Clinical Trials Overview 32

JMM Total Hip System – Product Status 32

JMM Total Hip System – Product Description 32

Konknow Hip System – Product Status 32

Konknow Hip System – Product Description 33

Corin Group Ltd Pipeline Products & Ongoing Clinical Trials Overview 34

Trinity Plus – Product Status 34

Trinity Plus – Product Description 34

CytexOrtho Pipeline Products & Ongoing Clinical Trials Overview 35

Bio-Artificial Cartilage Implant – Femoroacetabular Impingement – Product Status 35

Bio-Artificial Cartilage Implant – Femoroacetabular Impingement – Product Description 35

ReNew Hip Implant – Product Status 35

ReNew Hip Implant – Product Description 36

DePuy Synthes Inc Pipeline Products & Ongoing Clinical Trials Overview 37

Bone Preserving Hip Stem – Product Status 37

Bone Preserving Hip Stem – Product Description 37

PE ALTRX Polyethylene Liner – Product Status 37

PE ALTRX Polyethylene Liner – Product Description 38

Dynamic Implant Inc Pipeline Products & Ongoing Clinical Trials Overview 39

Dynamic Implant – Hip Arthritis – Product Status 39

Dynamic Implant – Hip Arthritis – Product Description 39

Embody Orthopaedic Ltd Pipeline Products & Ongoing Clinical Trials Overview 40

H1 Hip Resurfacing Implant – Product Status 40

H1 Hip Resurfacing Implant – Product Description 40

Embody Orthopaedic Ltd – Ongoing Clinical Trials Overview 41

H1 Hip Resurfacing Implant – The ACTIVE Trial: A Prospective Randomised Control Trial Of The H1 Implant Versus Total Hip Replacement 42

Exactech Inc Pipeline Products & Ongoing Clinical Trials Overview 43

Alteon Revision Modular System – Product Status 43

Alteon Revision Modular System – Product Description 43

Hip Revision System – Product Status 43

Hip Revision System – Product Description 44

Flexable Orthopedics Pipeline Products & Ongoing Clinical Trials Overview 45

Flex-Able – Product Status 45

Flex-Able – Product Description 45

Fortis Orthopedics Pipeline Products & Ongoing Clinical Trials Overview 46

MiHip System – Product Status 46

MiHip System – Product Description 46

Fraunhofer Institute for Applied Polymer Research Pipeline Products & Ongoing Clinical Trials Overview 47

Enhanced Durability Resurfacing Endoprosthesis – Product Status 47

Enhanced Durability Resurfacing Endoprosthesis – Product Description 47

Gyder Surgical Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview 48

Gyder Hip Navigation System – Product Status 48

Gyder Hip Navigation System – Product Description 48

Hip Innovation Technology LLC Pipeline Products & Ongoing Clinical Trials Overview 49

HIT Hip Replacement System – Product Status 49

HIT Hip Replacement System – Product Description 49

Hip Innovation Technology LLC – Ongoing Clinical Trials Overview 50

HIT Hip Replacement System – Safety and Effectiveness of the Hip Innovation Technology Reverse Hip Replacement System in Primary Total Hip Arthroplasty: A Pivotal Study 51

Implants International Ltd Pipeline Products & Ongoing Clinical Trials Overview 52

Phoenix Re-Surf – Product Status 52

Phoenix Re-Surf – Product Description 52

Inertial Orthopaedic Navigation Solutions (IONS) Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview 53

MACNAV Computer-Assisted Hip Replacement Navigation System – Product Status 53

MACNAV Computer-Assisted Hip Replacement Navigation System – Product Description 53

Inor Medical Products Ltd Pipeline Products & Ongoing Clinical Trials Overview 54

INOR TOTAL HIP SYSTEM Chromium Cobalt XL Series-LONG NECK – Product Status 54

INOR TOTAL HIP SYSTEM Chromium Cobalt XL Series-LONG NECK – Product Description 54

Inor Total Hip System Stainless Steel XL Series – Long Neck – Product Status 54

Inor Total Hip System Stainless Steel XL Series – Long Neck – Product Description 55

JointMedica Ltd Pipeline Products & Ongoing Clinical Trials Overview 56

The Polymotion Hip Resurfacing System – Product Status 56

The Polymotion Hip Resurfacing System – Product Description 56

JRI Orthopaedics Ltd Pipeline Products & Ongoing Clinical Trials Overview 57

Acetabular Cup Liner – Product Status 57

Acetabular Cup Liner – Product Description 57

Avanteon Hip System – Product Status 58

Avanteon Hip System – Product Description 58

Furlong Evolution – Product Status 58

Furlong Evolution – Product Description 59

Furlong H-A.C. Acetabular Cup – Product Status 59

Furlong H-A.C. Acetabular Cup – Product Description 59

Furlong H-A.C. Revision Hip Stem – Product Status 60

Furlong H-A.C. Revision Hip Stem – Product Description 60

Furlong Modular THR – Product Status 60

Furlong Modular THR – Product Description 61

Furlong Securus Femoral Revision System – Product Status 61

Furlong Securus Femoral Revision System – Product Description 62

MRS Comfort Revision Cup – Product Status 62

MRS Comfort Revision Cup – Product Description 62

JRI Orthopaedics Ltd – Ongoing Clinical Trials Overview 63

Avanteon Hip System – Prospective, Open Label, Single Arm, Monocentric Clinical Study Intended to Observe Efficacy and Safety of the Aeon-shaft (Artificial Hip Joint), Fa. Brehm, in Patients with Osteoarthritis of the Hip or a Fracture of the Femoral Neck 64

Lifespans Ltd Pipeline Products & Ongoing Clinical Trials Overview 65

Lifespans Soft Hip Implant – Product Status 65

Lifespans Soft Hip Implant – Product Description 65

Limacorporate SpA Pipeline Products & Ongoing Clinical Trials Overview 66

Mueller Cemented Cups – Product Status 66

Mueller Cemented Cups – Product Description 66

MicroPort Orthopedics Inc Pipeline Products & Ongoing Clinical Trials Overview 67

Classic Revision Stem – Product Status 67

Classic Revision Stem – Product Description 67

Hip Alignment Guide – Product Status 68

Hip Alignment Guide – Product Description 68

Prime Constrained Liner – Product Status 68

Prime Constrained Liner – Product Description 68

Procotyl P Acetabular Cup System – Product Status 69

Procotyl P Acetabular Cup System – Product Description 69

Profemur Cemented XM Femoral Stem – Product Status 69

Profemur Cemented XM Femoral Stem – Product Description 69

Zenith 3D Acetabular System – Product Status 70

Zenith 3D Acetabular System – Product Description 70

Zenith Acetabular System – Product Status 70

Zenith Acetabular System – Product Description 70

MicroPort Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 72

Next Generation Optimized ML Taper Hip Stem – Product Status 72

Next Generation Optimized ML Taper Hip Stem – Product Description 72

VenusOne 3D-Printed Acetabular System – Product Status 73

VenusOne 3D-Printed Acetabular System – Product Description 73

VenusOne Bio-Acetabular System – Product Status 73

VenusOne Bio-Acetabular System – Product Description 73

VenusOne Sintered-Ti Acetabular System – Product Status 74

VenusOne Sintered-Ti Acetabular System – Product Description 74

XL & E-POLY BIOFOAM – Product Status 74

XL & E-POLY BIOFOAM – Product Description 74

MX Orthopedics Corp Pipeline Products & Ongoing Clinical Trials Overview 76

Shape Memory Alloy Hip Implant – Product Status 76

Shape Memory Alloy Hip Implant – Product Description 76

Nano Interface Technology LLC (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 77

Hip Implant – Product Status 77

Hip Implant – Product Description 77

Ortho Development Corp Pipeline Products & Ongoing Clinical Trials Overview 78

Trivicta Hip Stem – Product Status 78

Trivicta Hip Stem – Product Description 78

OrthoGrid Systems Inc Pipeline Products & Ongoing Clinical Trials Overview 79

HipFXGrid – Product Status 79

HipFXGrid – Product Description 79

Orthopaedic International Inc Pipeline Products & Ongoing Clinical Trials Overview 80

Cementless Hip Replacement System – Product Status 80

Cementless Hip Replacement System – Product Description 80

PreSRV Ltd. Pipeline Products & Ongoing Clinical Trials Overview 81

Atlas Femoral Head Preserving Prosthesis – Product Status 81

Atlas Femoral Head Preserving Prosthesis – Product Description 81

Pro-Dex Inc Pipeline Products & Ongoing Clinical Trials Overview 82

Acetabular Cup Revision Tool – Product Status 82

Acetabular Cup Revision Tool – Product Description 82

Renova Orthopedics LLC (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 83

A-FX Hip Fracture System – Product Status 83

A-FX Hip Fracture System – Product Description 83

Rochester Institute of Technology Pipeline Products & Ongoing Clinical Trials Overview 84

Artificial Hip Joint – Product Status 84

Artificial Hip Joint – Product Description 84

SINTEF Pipeline Products & Ongoing Clinical Trials Overview 85

Smart Hip Prosthesis – Product Status 85

Smart Hip Prosthesis – Product Description 85

SINTX Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 86

Infinia Total Hip Implant II – Product Status 86

Infinia Total Hip Implant II – Product Description 86

Total Hip Implant – Product Status 87

Total Hip Implant – Product Description 87

Smith & Nephew Plc Pipeline Products & Ongoing Clinical Trials Overview 88

Navio Total Hip Arthroplasty System – Product Status 88

Navio Total Hip Arthroplasty System – Product Description 88

Total Hip Arthroplasty Instrument – Product Status 89

Total Hip Arthroplasty Instrument – Product Description 89

Stanford University Pipeline Products & Ongoing Clinical Trials Overview 90

Avascular Necrosis Implant – Product Status 90

Avascular Necrosis Implant – Product Description 90

Bioactive Functionally-Graded Implant – Osteonecrosis – Product Status 90

Bioactive Functionally-Graded Implant – Osteonecrosis – Product Description 91

University of Auckland Pipeline Products & Ongoing Clinical Trials Overview 92

Acetabular Reconstruction Implant – Product Status 92

Acetabular Reconstruction Implant – Product Description 92

University of Cincinnati Pipeline Products & Ongoing Clinical Trials Overview 93

Acetabular Reaming/Impacting Guide – Product Status 93

Acetabular Reaming/Impacting Guide – Product Description 93

University of Maine Pipeline Products & Ongoing Clinical Trials Overview 94

Stemless Hip Replacement Prosthesis – Product Status 94

Stemless Hip Replacement Prosthesis – Product Description 94

University of Oxford Pipeline Products & Ongoing Clinical Trials Overview 95

Surgical Device – Hip Replacement – Product Status 95

Surgical Device – Hip Replacement – Product Description 95

University of South Florida Pipeline Products & Ongoing Clinical Trials Overview 96

Cannulated Screw Jig – Product Status 96

Cannulated Screw Jig – Product Description 96

Injectable Hip Hemiarthroplasty Device – Product Status 96

Injectable Hip Hemiarthroplasty Device – Product Description 97

University of Southampton Pipeline Products & Ongoing Clinical Trials Overview 98

EnDuRE – Product Status 98

EnDuRE – Product Description 98

University of Warwick Pipeline Products & Ongoing Clinical Trials Overview 99

Femoral Head Positioning Device – Product Status 99

Femoral Head Positioning Device – Product Description 99

Hip Prostheses – Product Status 99

Hip Prostheses – Product Description 100

Zimmer Biomet Holdings Inc Pipeline Products & Ongoing Clinical Trials Overview 101

E1 Avantage Hip Cup – Product Status 101

E1 Avantage Hip Cup – Product Description 101

Figures

Hip Reconstruction – Pipeline Products by Stage of Development 14

Hip Reconstruction – Pipeline Products by Segment 15

Hip Reconstruction – Pipeline Products by Territory 16

Hip Reconstruction – Pipeline Products by Regulatory Path 17

Hip Reconstruction – Pipeline Products by Estimated Approval Date 18

Hip Reconstruction – Ongoing Clinical Trials 19

Frequently asked questions

Hip Reconstruction Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies standard reports
Currency USD
$4,000

Can be used by individual purchaser only

$12,000

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company


Undecided about purchasing this report?

Enquire Before Buying Download FREE Resources

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

Sample Report

Hip Reconstruction Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies was curated by the best experts in the industry and we are confident about its unique quality. However, we want you to make the most beneficial decision for your business, so we offer free sample pages to help you:

  • Assess the relevance of the report
  • Evaluate the quality of the report
  • Justify the cost

Download your copy of the sample report and make an informed decision about whether the full report will provide you with the insights and information you need.

Below is a sample report to understand what you are buying

See what our customers are saying
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

Senior Account Manager, TSYS
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at Hip Reconstruction Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies in real time.

  • Access a live Hip Reconstruction Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.